| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.45 | 0.002 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |